Skip to main content

Abbott Laboratories

41 ongoing recalls and 24 historical records

Based on the official records currently available to Public Health Trace, 41 recalls naming Abbott Laboratories are currently shown as ongoing. The other 24 records below are historical.

Public Health Trace has 65 recalls naming Abbott Laboratories as the recalling firm, republished from official FDA and USDA sources.

Recall records - 65 total

Recalls by year

A bar chart of the number of recalls naming this company by year.

Recalls by year
YearRecalls
20124
20131
20191
202257
20232
Download CSV

FDA Recall TerminatedTerminated: July 10, 2015Historical recordClass II

Synthroid (Levothyroxine Sodium) tablets, 150 mcg (0.15 mg), 90 tablets per bottle, Rx Only, NDC 0074-7069-90; ABBOTT LABORATORIES NORTH CHICAGO, IL 60064 U.S.A.

by Abbott Laboratories

Reason
Labeling: Error on Declared Strength. Product labeled to contain 150 mcg tablets actually contained 75 mcg tablets.
Published
January 9, 2013
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: November 1, 2013Historical recordClass II

Synthroid (levothyroxine sodium) Tablets USP, 112 mcg, Rx Only, 90-Count Bottle, Abbott Laboratories, North Chicago, IL 60064, NDC: 0074-9296-90

by Abbott Laboratories

Reason
Defective Container: A number of Synthroid bottles have a localized thin wall defect on the bottom which may potentially impact the stability of the tablets.
Published
October 3, 2012
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: November 1, 2013Historical recordClass II

Synthroid (levothyroxine sodium) Tablets USP, 75 mcg, Rx Only, 90-Count Bottle, Abbott Laboratories, North Chicago, IL 60064, NDC: 0074-5182-90.

by Abbott Laboratories

Reason
Defective Container: A number of Synthroid bottles have a localized thin wall defect on the bottom which may potentially impact the stability of the tablets.
Published
October 3, 2012
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: November 1, 2013Historical recordClass II

Synthroid (levothyroxine sodium) Tablets USP, 50 mcg, Rx Only, 90-Count Bottle, Abbott Laboratories, North Chicago, IL 60064, NDC: 0074-4552-90.

by Abbott Laboratories

Reason
Defective Container: A number of Synthroid bottles have a localized thin wall defect on the bottom which may potentially impact the stability of the tablets.
Published
October 3, 2012
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: December 3, 2012Historical recordClass II

Zemplar (paricalcitol) Injection, 5 mcg/mL in 2 mL multi-dose vials, 25 vial carton, Rx only, Manufactured by Hospira, Inc. For Abbott Laboratories, North Chicago, IL 60064, USA, NDC 0074-1658-05

by Abbott Laboratories

Reason
CGMP Deviations: There is potential that Abbott's third party manufacturer, Hospira, may have applied a foreign (incorrect) stopper to vials in a specific lot of Zemplar Injection.
Published
June 27, 2012
Distribution
Nationwide

View recall →

Some FDA recall records on this page come from FDA's Enforcement Report database. Not every Enforcement Report record has a separate FDA.gov recall-announcement page.

This page lists recalls that name Abbott Laboratories as the recalling firm in the official source notice. It is not a safety rating, ranking, or statement that the company acted negligently. Read the full medical disclaimer.

Reconnecting to the server…

We lost the connection to the server.

Your session has expired.